Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK LIFE SCIENCES vs MERCURY LAB. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLENMARK LIFE SCIENCES MERCURY LAB. GLENMARK LIFE SCIENCES/
MERCURY LAB.
 
P/E (TTM) x 18.3 24.3 75.3% View Chart
P/BV x 4.5 2.2 203.7% View Chart
Dividend Yield % 2.7 0.4 644.0%  

Financials

 GLENMARK LIFE SCIENCES   MERCURY LAB.
EQUITY SHARE DATA
    GLENMARK LIFE SCIENCES
Mar-23
MERCURY LAB.
Mar-23
GLENMARK LIFE SCIENCES/
MERCURY LAB.
5-Yr Chart
Click to enlarge
High Rs5341,000 53.4%   
Low Rs369390 94.6%   
Sales per share (Unadj.) Rs176.4627.8 28.1%  
Earnings per share (Unadj.) Rs38.146.5 82.0%  
Cash flow per share (Unadj.) Rs41.567.2 61.8%  
Dividends per share (Unadj.) Rs21.003.50 600.0%  
Avg Dividend yield %4.70.5 923.6%  
Book value per share (Unadj.) Rs174.0380.2 45.7%  
Shares outstanding (eoy) m122.531.20 10,210.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.61.1 231.2%   
Avg P/E ratio x11.814.9 79.2%  
P/CF ratio (eoy) x10.910.3 105.1%  
Price / Book Value ratio x2.61.8 142.0%  
Dividend payout %55.17.5 731.9%   
Avg Mkt Cap Rs m55,321834 6,633.2%   
No. of employees `000NANA-   
Total wages/salary Rs m1,802139 1,295.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m21,612753 2,868.9%  
Other income Rs m29017 1,684.5%   
Total revenues Rs m21,902771 2,842.4%   
Gross profit Rs m6,42386 7,452.1%  
Depreciation Rs m42125 1,695.3%   
Interest Rs m54 151.1%   
Profit before tax Rs m6,28675 8,389.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,61619 8,445.6%   
Profit after tax Rs m4,67056 8,370.0%  
Gross profit margin %29.711.4 259.8%  
Effective tax rate %25.725.5 100.7%   
Net profit margin %21.67.4 291.8%  
BALANCE SHEET DATA
Current assets Rs m23,687417 5,679.1%   
Current liabilities Rs m10,228164 6,225.7%   
Net working cap to sales %62.333.6 185.6%  
Current ratio x2.32.5 91.2%  
Inventory Days Days27 22.6%  
Debtors Days Days1361,035 13.2%  
Net fixed assets Rs m8,518259 3,293.0%   
Share capital Rs m24512 2,042.1%   
"Free" reserves Rs m21,070444 4,742.4%   
Net worth Rs m21,315456 4,671.4%   
Long term debt Rs m024 0.0%   
Total assets Rs m32,205676 4,765.8%  
Interest coverage x1,150.221.7 5,300.7%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.71.1 60.2%   
Return on assets %14.58.8 165.1%  
Return on equity %21.912.2 179.2%  
Return on capital %29.516.3 180.6%  
Exports to sales %025.3 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA191 0.0%   
Imports (cif) Rs mNA3 0.0%   
Fx inflow Rs m9,691191 5,079.8%   
Fx outflow Rs m5,0018 63,306.8%   
Net fx Rs m4,689183 2,564.3%   
CASH FLOW
From Operations Rs m3,13425 12,781.6%  
From Investments Rs m-1,541-11 14,583.3%  
From Financial Activity Rs m-3,876-10 38,261.9%  
Net Cashflow Rs m-2,2834 -59,617.2%  

Share Holding

Indian Promoters % 82.9 73.7 112.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.3 0.0 -  
FIIs % 4.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 17.2 26.3 65.1%  
Shareholders   185,531 1,161 15,980.3%  
Pledged promoter(s) holding % 9.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLENMARK LIFE SCIENCES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GLENMARK LIFE SCIENCES vs MERCURY LAB.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GLENMARK LIFE SCIENCES vs MERCURY LAB. Share Price Performance

Period GLENMARK LIFE SCIENCES MERCURY LAB. S&P BSE HEALTHCARE
1-Day 0.01% -4.12% 1.18%
1-Month -11.59% -3.92% -0.75%
1-Year 106.25% 56.06% 61.82%
3-Year CAGR 1.19% 9.86% 18.16%
5-Year CAGR 0.71% 20.84% 19.79%

* Compound Annual Growth Rate

Here are more details on the GLENMARK LIFE SCIENCES share price and the MERCURY LAB. share price.

Moving on to shareholding structures...

The promoters of GLENMARK LIFE SCIENCES hold a 82.9% stake in the company. In case of MERCURY LAB. the stake stands at 73.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GLENMARK LIFE SCIENCES and the shareholding pattern of MERCURY LAB..

Finally, a word on dividends...

In the most recent financial year, GLENMARK LIFE SCIENCES paid a dividend of Rs 21.0 per share. This amounted to a Dividend Payout ratio of 55.1%.

MERCURY LAB. paid Rs 3.5, and its dividend payout ratio stood at 7.5%.

You may visit here to review the dividend history of GLENMARK LIFE SCIENCES, and the dividend history of MERCURY LAB..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.